-Dr. Carl Sagan
Register for our critical thinking resources for educators
About Us
Born out of the first meeting of five activists regarding the "Business of Science" symposium being held October 27-28th 2005 at the Fairmont Hotel, "Enclosing the Commons" begins with a belief that science should be critical, and the commons should be for all...not for sale.
While the Business of Science symposium is two days long, the issues of biotechnology, nanotechnology and the pharmeceutical industries are bound to have long term effects on the economy of Manitoba, and devastating effects the world over. If the Manitoba government supports paying millions of dollars of funding profitable private corporations the balanced approach should require equal funding for critical debate and public scrutiny of this practice labelled as science.
Enclosing The Commons is to become a resource for those who wish to challenge the undemocratic and unscientific approach that multinational industries have, which amount to a well funded PR campaign. It will also act as a resource for those who wish to create a critical look at the science behind biotech and nanotech within the media and the public and it's broader ramifications.
Our first goal is to create opposition, criticism, and awareness to the BofS symposium. We invite participation in an educational campaign, pressure to hold accountable those affecting public safety through a little debated subject, establishment of sound, well researched methods. In short we are calling for a scientific, democratic, critical public engagement of these technologies and the way it affects our lives.
Introducing Monsanto
Monsanto is a multinational agricultural biotech corporation. The company is the leading producer of genetically engineered (GE) seed. It's 2005 annual revenue was $5.23 billion (fiscal year end Aug 2005). In the 1940s, they were active in the Manhattan Project, helping to develop the first nuclear weapons. They were also the leading producer of Agent Orange in the '60s and '70s. In 2003, Monsanto sued a dairy in Maine for advertising that its milk products did not come from cows treated with its bovine growth hormone, claiming that such advertising hurt its business. They have been sued in numerous cases over the health and environmental effects of their products.
Seed Industry Concentration 2005 - ETC
According to ETC Group, the top 10 multinational seed firms control half of the world's commercial seed sales (a total worldwide market of approximately US$21,000 million per annum). Corporate control and ownership of seeds - the first link in the food chain - has far-reaching implications for global food security. With control of seeds and agricultural research held in fewer hands, the world's food supply is increasingly vulnerable to the whims of market maneuvers. ETC Group's report includes a table listing many of the world's top 20 seed companies and their acquisitions and/or subsidiaries.
Know your sponsors: Pharma
Who are your sponsors?
Pharmaceuticals
In 2004, the pharmaceutical industry had a global revenue of $550 billion (US). Among the top 10 selling companies worldwide are several of this symposium’s sponsors:
Pfizer ($46.13 billion)
GlaxoSmithKline ($31.38 billion)
Sanofi-Aventis ($30.92 billion)
Merck ($21.49 billion)
AstraZeneca ($21.43 billion)
Wyeth ($13.94 B)
In September 2004, Merck pulled its arthritis drug Vioxx off the market after a Food and Drug Administration study linked Vioxx to 27 000 sudden deaths and heart attacks in the between 1999 and 2003. Vioxx had been marketed in 80 countries and generated $2.5 billion in sales in 2003. The FDA, a government agency, tried to block the publication of the study.
"The senior executives at Merck and the leadership at the FDA share responsibility for not having taken appropriate action and not recognizing that they are accountable for the public health. … Meanwhile, Merck was spending more than $100 million a year in direct-to-consumer advertising — another activity regulated by the FDA and a critical mechanism in building the 'blockbuster' status of a drug."
Corporations
The purpose of a corporation
A corporation is a group of people that has been given the legal status to act as a kind of "artificial person". The law gives a corporation certain rights like the ability to own property, sign contracts and pay taxes.
Shareholders are people who invest money in a corporation by buying shares through the stock market. These people are involved in making decisions regarding the behaviour of the corporation. However, those who have invested the most money are granted the most decision-making power. This is like having a political system where you get more votes the more money you have, instead of democracy with its one-person/one-vote system.
Links
Lets get our links in order! How do we create a new page (not just another story?), so the links page is only a link to the page on the main? Thanks
Resource Sites:
Academic Commons
Academe September 2002 Issue - Who owns your ideas?
Project Communis is a multimedia journal of politics, privatization and the public good. It is maintained by activist and graduate student Rob Maguire, from Atlantic Canada.
Democracy and the Common Good
"Who owns the patent on this vaccine?" Edward R. Murrow, Radio & TV Journalist
"Well, the people, I would say. There is no patent. COuld you patent the sun?" Jonas Salk, Inventor of the Polio Vaccine.
What is most valuable to you? Is it your house, your car? What about your planet?
All private possessions are derived from the goods we share in common - earth, air, water, and the collected sum of all human knowledge and experience, including science.
Science and the commons are increasingly being threatened by our wanton destruction, blatant disregard and diastrous misinterpretation of what science and the commons really are.
We have the right to own things. But where does the line get drawn? Who owns the works of the ancients, and should our greatest discoveries be in the hands of a few?
In a publicly participated democracy, the centuries of generations who have contributed to our way of life and knowledge base would be shared. Should be shared. Progress depends upon our ability to own commonly the knowledge gained.
These days, the patent process is so overblown that it is now extending into the realm of DNA. And it is greatly hindering, not helping, progress and humanity.
"Patents for living organisms impoverish human society ethically, ecologically, and economically." Vandana Shiva, Physicist and writer.
Our democracy is dependant on our common goods. As we wither away our commons, we have less and less common space. Common space is where the poor and rich meet on equal footing. It is where we can share one another's company, without having to pay a cover price. It is where the rights to free speech and assembly are protected.
We must protect what is common to all: The land, waterways, knowledge, the Internet, the sky, airwaves, public space, and our rights. The commons are very much like our democracy - not something which we can idly continue to have, but must actively continue to be vigilant in protecting and expanding.
"The law doth punish man or woman
That steals the goose from off the common,
But lets the greater felon loose,
That steals the common from the goose."
Academic Freedom
Academic freedom
From Wikipedia, the free encyclopedia.
Academic freedom is a widely used and championed phrase, but an often poorly defined concept with different meanings in different cultures and different contexts. It can refer to the alleged right of students, teachers or academic institutions to do or be protected from a number of different things.
LIST OF RESOURCES, EVENTS, ACTION
http://www.i-sis.org.uk/Big_Business-Bad_Science.php - The Institute of Science in Society, London
http://www.monsanto.ca
http://www.gov.mb.ca/est/rit/lifesc/index.html - Manitoba’s Life Sciences
http://www.canadians.org – Council of Canadians (link to GE Free Canada Campaign)
http://www.policyalternatives.ca/ - Cdn. Centre for Policy Alternatives – search under “Biotechnology”
Ethics, Public Policy & the Pharmaceutical Industry
Thursday, November 3, 2005 at 7:30 p.m.
Eckhardt-Gramatté Hall (3rd Floor Centennial Hall)
University of Winnipeg
What is Science?
From Wikipedia, the free encyclopedia.
- For the scientific journal named Science, see Science Magazine.
Science is two things:
About Monsanto
Monsanto Company NYSE: MON is a multinational agricultural biotechnology corporation. It is the world's leading producer of the herbicide glyphosate, marketed as its flagship product, Roundup. Monsanto is also by far the leading producer of genetically engineered (GE) seed, holding 70%–100% market share for various crops. Agracetus, owned by Monsanto, exclusively produces Roundup Ready soybean seed for the commercial market. In March 2005, it finalized the purchase of Seminis Inc, making it also the largest conventional seed company in the world. It has over 15,000 employees worldwide, and an annual revenue of $5.4 billion US reported for August, 2004.
Propaganda and Dialogue
Appeal to authority: Tell people that an "expert" believes something is true.
Argumentum ad nauseum: Repeat something often enough that people take it as truth, even though they've never seen proof.
What is science?
Discussion of what composes rigorous scientific method, principals and practice.
Meeting Today (wednesday)
Time: 2.30 pm
Place: Bulman Student Centre main floor, University of Winnipeg
A group of concerned citizens is calling for an organizating meeting to prepare and discuss actions for Friday the 28th at the Business of Science symposium at the University of Manitoba.
The symposium is being sponsored by the Government of Manitoba and a slew of multinational pharmaceutical, biomedical and biotech corporations, such as Monsanto, Biovail, and Pfizer. The symposium will, according to the website, feature:
Business development benchmarking
Tours of world-class life science facilities
Some Relevant Links
Manitoban Feature Article:
http://umanitoba.ca/manitoban/2005-2006/1005/815.seeds.of.change.unsown.php
Manitoba Cooperator:
http://www.agcanada.com/custompages/stories_story.aspx?mid=22&id=563
Winnipeg Free Press:
http://www.organicconsumers.org/ge/grainfilm091505.cfm
Program Schedule
Manitoba Business of Science Symposium 2005
Thursday, October 27, 2005
CLOSED
INTERACTIVE BREAKFAST
SESSION FULL
Hosted by Smartpark Research and Technology Park, University of Manitoba Nanotechnology: Emerging Biomedical Applications and Markets
Over the past three years, nanotechnology has begun to take the shape of big business, with numerous companies spun off from academia, and worldwide government and private investment increasing annually. This session will present an overview of nanotechnologyrelated research and development activities targeting biomedical research, diagnostic tools and therapeutics, and the consequences that such development will have on the focus on the healthcare industry. Speaker · Dr. Stephane Evoy, Leader of the Devices and Sensors Group, National Institute for Nanotechnology and Assistant Professor, Electrical and Computer Engineering, University of Alberta

